Literature DB >> 15362179

A comparison of the EQ-5D and SF-6D across seven patient groups.

John Brazier1, Jennifer Roberts, Aki Tsuchiya, Jan Busschbach.   

Abstract

As the number of preference-based instruments grows, it becomes increasingly important to compare different preference-based measures of health in order to inform an important debate on the choice of instrument. This paper presents a comparison of two of them, the EQ-5D and the SF-6D (recently developed from the SF-36) across seven patient/population groups (chronic obstructive airways disease, osteoarthritis, irritable bowel syndrome, lower back pain, leg ulcers, post menopausal women and elderly). The mean SF-6D index value was found to exceed the EQ-5D by 0.045 and the intraclass correlation coefficient between them was 0.51. Whilst this convergence lends some support for the validity of these measures, the modest difference at the aggregate level masks more significant differences in agreement across the patient groups and over severity of illness, with the SF-6D having a smaller range and lower variance in values. There is evidence for floor effects in the SF-6D and ceiling effects in the EQ-5D. These discrepancies arise from differences in their health state classifications and the methods used to value them. Further research is required to fully understand the respective roles of the descriptive systems and the valuation methods and to examine the implications for estimates of the impact of health care interventions.

Entities:  

Mesh:

Year:  2004        PMID: 15362179     DOI: 10.1002/hec.866

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  274 in total

1.  The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors:  Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal:  Eur J Health Econ       Date:  2011-11-05

2.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

3.  Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients.

Authors:  Lene Lunde
Journal:  Eur J Health Econ       Date:  2012-06-08

4.  A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?

Authors:  Jennifer C Davis; Teresa Liu-Ambrose; Chris G Richardson; Stirling Bryan
Journal:  Qual Life Res       Date:  2012-06-22       Impact factor: 4.147

5.  The impact of social isolation on the health status and health-related quality of life of older people.

Authors:  Annie Hawton; Colin Green; Andy P Dickens; Suzanne H Richards; Rod S Taylor; Rachel Edwards; Colin J Greaves; John L Campbell
Journal:  Qual Life Res       Date:  2010-07-25       Impact factor: 4.147

6.  Toward a more universal approach in health valuation.

Authors:  Benjamin M Craig; Jan J V Busschbach
Journal:  Health Econ       Date:  2011-07       Impact factor: 3.046

7.  Clinical characteristics of persistent frequent attenders in primary care: case-control study.

Authors:  Shireen Patel; Joe Kai; Christopher Atha; Anthony Avery; Boliang Guo; Marilyn James; Samuel Malins; Christopher Sampson; Michelle Stubley; Richard Morriss
Journal:  Fam Pract       Date:  2015-10-08       Impact factor: 2.267

8.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

9.  Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Authors:  Carmen Selva-Sevilla; Paula Ferrara; Manuel Gerónimo-Pardo
Journal:  Eur J Health Econ       Date:  2020-02-17

10.  The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.

Authors:  Meridith E Greene; Kevin A Rader; Göran Garellick; Henrik Malchau; Andrew A Freiberg; Ola Rolfson
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.